Predicting and Managing Treatment Non-response in Posttraumatic Stress Disorder

被引:26
作者
Fonzo G.A. [1 ]
Federchenco V. [2 ]
Lara A. [2 ]
机构
[1] Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin
[2] General Psychiatry Residency, Dell Medical School, The University of Texas at Austin, Austin
关键词
Posttraumatic stress; Predictor; Psychotherapy; PTSD; Treatment resistant;
D O I
10.1007/s40501-020-00203-1
中图分类号
学科分类号
摘要
Purpose of review: This review aims to synthesize existing research regarding the definition of treatment resistance in posttraumatic stress disorder (PTSD), predictors of treatment non-response to first-line interventions, and emerging second-line PTSD treatment options into an accessible resource for the practicing clinician. Recent findings: The concept of treatment resistance in PTSD is currently poorly defined and operationalized. There are no well-established predictors of treatment non-response utilized in routine clinical care, but existing research identifies several potential candidate markers, including male gender, low social support, chronic and early life trauma exposure, comorbid psychiatric disorders, severe PTSD symptoms, and poor physical health. The most promising available treatment options for PTSD patients non-responsive to first-line psychotherapies and antidepressants include transcranial magnetic stimulation and ketamine infusion. Methylenedioxymethamphetamine-assisted psychotherapy also appears promising but is only available in a research context. These options require careful consideration of risks and benefits for a particular patient. Summary: More research is required to develop a robust, clinically useful definition of treatment resistance in PTSD; identify reliable, readily assessable, and generalizable predictors of PTSD treatment non-response; and implement measurement and prediction in clinical settings to identify individuals unlikely to respond to first-line treatments and direct them to appropriate second-line treatments. © 2020, Springer Nature Switzerland AG.
引用
收藏
页码:70 / 87
页数:17
相关论文
共 106 条
[1]  
Seal K.H., Metzler T.J., Gima K.S., Bertenthal D., Maguen S., Marmar C.R., Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008, Am J Public Health, 99, 9, pp. 1651-1658, (2009)
[2]  
Marmar C.R., Schlenger W., Henn-Haase C., Qian M., Purchia E., Li M., Et al., Course of posttraumatic stress disorder 40 years after the Vietnam war: findings from the National Vietnam Veterans Longitudinal Study, JAMA Psychiatry, 72, 9, pp. 875-881, (2015)
[3]  
Schnurr P.P., Lunney C.A., Bovin M.J., Marx B.P., Posttraumatic stress disorder and quality of life: extension of findings to veterans of the wars in Iraq and Afghanistan, Clin Psychol Rev, 29, 8, pp. 727-735, (2009)
[4]  
Cusack K., Jonas D.E., Forneris C.A., Wines C., Sonis J., Middleton J.C., Et al., Psychological treatments for adults with posttraumatic stress disorder: a systematic review and meta-analysis, Clin Psychol Rev, 43, pp. 128-141, (2016)
[5]  
Stein D.J., Ipser J.C., Seedat S., Pharmacotherapy for post traumatic stress disorder (PTSD), Cochrane Database Syst Rev, 1, (2006)
[6]  
Koek R.J., Schwartz H.N., Scully S., Langevin J.-P., Spangler S., Korotinsky A., Et al., Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future, Prog Neuro-Psychopharmacol Biol Psychiatry, 70, pp. 170-218, (2016)
[7]  
Schottenbauer M.A., Glass C.R., Arnkoff D.B., Tendick V., Gray S.H., Nonresponse and dropout rates in outcome studies on PTSD: review and methodological considerations, Psychiatry., 71, 2, pp. 134-168, (2008)
[8]  
Clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder, (2017)
[9]  
A Second Major Evidence-Based Guideline for the Treatment of PTSD, (2017)
[10]  
Foa E.B., Hembree E.A., Rothbaum B.O., Rauch S.A., Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences. Second ed. treatments that work, (2019)